清晰突变驱动乳腺组织中的野外癌症的机制
Marta Ciwinska1, Hendrik A Messal2, Hristina R Hristova2
1VIB-KULeuven Centre for Cancer Biology, Department of Oncology, Leuven, Belgium.
Nature
|September 4, 2024
概括
尽管有大量的致癌突变, 但健康的组织通过三个保护层来预防瘤. 这些机制消除了大多数突变细胞,但允许一些细胞扩大,可能导致野外癌症.
科学领域:
- 细胞生物学
- 癌症研究
- 发育生物学
背景情况:
- 瘤突变在健康组织中很常见,但很少引起瘤.
- 防止瘤形成的保护机制尚不清楚.
研究的目的:
- 研究小鼠乳腺组织对瘤突变的保护机制.
- 了解突变细胞是如何被消除或导致瘤发展的.
主要方法:
- 在野生型和Brca1-/-;Trp53-/-小鼠乳腺组织中追踪细胞命运.
- 克隆分析用于研究乳腺管内的细胞动态.
主要成果:
- 乳腺管包含自我更新的干细胞和短命的后代,通过消除大多数新突变提供第一个保护层.
- 在雌性周期期间组织重塑提供了第二层保护,消除了大多数突变克隆,但允许一些扩张.
- 导管几何学施加了第三层保护,抑制了克隆的扩张,并导致幸存的克隆中的野外癌症.
结论:
- 在乳腺组织中存在多层保护,以消除具有瘤突变的细胞.
- 虽然大多数突变都被清除了,但少数可以扩大,导致广泛的突变细胞群体,并使组织易患癌症.
- 了解这些机制对于癌症预防和治疗策略至关重要.
更多相关视频
07:45Orthotopic Transplantation of Breast Tumors as Preclinical Models for Breast Cancer
Published on: May 18, 2020
6.0K
07:13Initiation of Metastatic Breast Carcinoma by Targeting of the Ductal Epithelium with Adenovirus-Cre: A Novel Transgenic Mouse Model of Breast Cancer
Published on: March 26, 2014
23.3K
相关概念视频
Cancers Originate from Somatic Mutations in a Single Cell
11.8K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
11.8K
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Tumor Progression
6.3K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K
Mutagenicity and Carcinogenicity
1.2K
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
1.2K
Cancer-Critical Genes I: Proto-oncogenes
8.7K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.7K
Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
